Antheia
antheia.bio
Actively hiring
Drug Discovery
Synthetic Biology
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$56.4M
10 rounds on record
Latest round
$17M
Venture round · Oct 2026 · this month
Team
58
US Form 5500 (plan participants) · Dec 2025 · +14% in a year
Hiring now
3
+2 posted in 30 days
Grants
$1.6M
5 grants · CORDIS
The money's age
Fresh money
0 months since the last round · and hiring
Momentum
62/100
hiring for its size, in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 6
Raised a round Venture round $17M
Jan 27
Raised a round Series C $24M · YahooFinance
Jun 22, 2022
Took on debt financing $40M · PRNewswire
Feb 22, 2022
New executive Antheia Appoints Heidi Pucel as Chief People Officer · PRNewswire
Aug 12, 2021
Partnership Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology · markets.businessinsider.com
Aug 22, 2018
Raised a round Venture round $9.2M · SEC Form D
May 17, 2017
Raised a round Venture round $6.2M · SEC Form D
2013
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2026 | $17M | — | pharmexec.com |
| Series C | Jan 2026 | $24M | — | YahooFinance |
| Debt Financing | Jun 2022 | $40M | — | PRNewswire |
| Venture round | Aug 2018 | $9.2M | — | SEC Form D |
| Grant | Mar 2018 | $734k | — | CORDIS |
| Venture round | May 2017 | $6.2M | — | SEC Form D |
| Grant | Apr 2017 | $225k | — | CORDIS |
| Grant | Jan 2017 | $225k | — | CORDIS |
| Grant | Jul 2016 | $225k | — | CORDIS |
| Grant | Jul 2016 | $225k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Antheia, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Christina SmolkeExecutive Officer, DirectorSEC Form D
Valerie MinassianExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance…
Synlogic is the leading company advancing therapeutics based on synthetic biology, working at the intersection of biology and engineering…
Early detection. Smarter farming. Healthier planet. We use synthetic biology to turn invisible plant stress signals into visible early…
IMicrobes: Accelerating the transition to sustainable materials through synthetic biology -Our programmable microbes turn ethanol into…
Vilya creates macrocycles using AI and synthetic biology, designing novel therapeutics inspired by nature, beyond evolution’s reach.
Infrastructure and intelligence for bioprocess — for development and manufacturing teams at biopharma, synthetic biology, and CDMOs.
News
Antheia Announces $17 Million in Funding for Domestic Pharmaceutical Ingredient Production PharmExec
The company received the money through a government project agreement.
Read more
Report
Introducing Stefan Bauer, Senior Director, Analytical Development
In today's blog, we are pleased to introduce Stefan Bauer, Senior Director, Analytical Development. The post Introducing Stefan Bauer, Senior Director, Analytical Development appeared first on Antheia.
Read more
Report
Inside Antheia's Analytical Development Standards
In biomanufacturing, the quality of measurement is critical to the scaleup and commercialization process. We spoke with Arlie Lehmkuhler, Scientist II on Antheia's Analytical Development team, about why precise measurement data is the foundation of a more
Read more
Report
Earth's mightiest manufacturers: FDA pilot to supercharge US drug production
The US Food and Drug Administration (FDA) has announced the launch of its PreCheck Pilot program with the goal of investing in and strengthening domestic manufacturing of pharmaceuticals. The post Earth's mightiest manufacturers: FDA pilot to supercharge
Read more
Report
The latest from Antheia: new job openings and CEO's perspective on pharma onshoring
Drug shortages in the U.S. are a systemic problem, but American innovation is our best bet to solving it. In a new article, Antheia CEO and co-founder Dr. Christina Smolke lays out why this moment demands urgency, and what a domestic solution looks like.
Read more
Report
America Still Has a Drug Shortage Problem, but American Innovation Can Fix It.
Onshoring existing and outdated manufacturing technologies to the U.S. is not the answer. What's needed is next-generation technology that can compete on cost and time, and provide resilient, agile, and distributed production of critical medicines. The so
Read more
Report
Introducing Adam Takos, Vice President of Drug Innovation and Managing Director of Singapore
In today's blog, we are pleased to introduce Adam Takos, Vice President of Drug Innovation and Managing Director of Singapore. The post Introducing Adam Takos, Vice President of Drug Innovation and Managing Director of Singapore appeared first on Antheia.
Read more
Report
How the Iran war is quietly testing global drug supply chains
The closure of the Strait of Hormuz by Iran is usually discussed in the language of geopolitics and energy markets. It is a chokepoint for oil, a pressure valve for global trade, and a lever of military strategy. But beneath those familiar headlines lies
Read more
Report
Introducing Andrew Saarni, Director, Fermentation Process Development & Scale-Up
In today's blog, we are pleased to introduce Andrew Saarni, Head of Fermentation Process Development & Scale-Up at Antheia. The post Introducing Andrew Saarni, Director, Fermentation Process Development & Scale-Up appeared first on Antheia.
Read more
Report
Antheia's Role in Onshoring America's Critical Medicine Supply
As we head into spring, the urgency around onshoring America's critical medicine supply chains has never been clearer or better supported. The post Antheia's Role in Onshoring America's Critical Medicine Supply appeared first on Antheia.
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Antheia over the last 12 months, by layer, with the share of postings for each.
Technologies in use
2
Postings analysed
2
Stack modernity
53/100
Developer tools
AutoCAD
Microsoft Excel
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$168k
Typical range
$100k – $235k
Open positions
2
2
Jobs
Middle
50%
Senior
50%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Middle | 1 | $100k | $100k |
| Senior | 1 | $235k | $235k |
Highest paying role
Sr. Director of Facilities Operations and Capital Projects (HYBRID)
$235k
Normalized to USD per year
People
Christina Smolke
Executive Officer, Director
Valerie Minassian
Executive Officer
Catherine Thodey
Director
Ram Shriram
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
28/100
Slowing
Open positions
3
0 opened / 0 closed in 30 days
Median time-to-fill
20 days
faster than 52% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Operations
50% ▲
Science & Research
50% ▲
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
1
Countries
2
Busiest office
Menlo Park
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Menlo Park
United States
HQ
Antheia
4 open roles 3 posted in 90 days 50% engineering $168k Avg Salary
hires for Operations, Science & Research
1430 O'Brien Drive, Suite A, Menlo Park, CA 94025
Singapore
Singapore
Regional office
Singapore
1 posted in 90 days
Financials
Total raised
$98M
Latest round
Venture - Series Unknown
Funding rounds
10
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $17M | Details |
| Series C | 2026 | $24M | Details |
| Debt Financing | 2022 | $40M | Details |
| Venture - Series Unknown | 2018 | $9.2M | Details |
| Grant | 2018 | $734k | Details |
| Venture - Series Unknown | 2017 | $6.2M | Details |
| Grant | 2017 | $225k | Details |
| Grant | 2017 | $225k | Details |
| Grant | 2016 | $225k | Details |
| Grant | 2016 | $225k | Details |